Avanos Medical, Inc.
AVNS
$12.43
$0.373.07%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -574.87% | 130.37% | 131.67% | -231.17% | -215.05% |
| Total Depreciation and Amortization | 29.63% | 24.05% | -29.63% | -29.36% | -26.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 535.29% | -86.63% | -91.65% | 365.52% | 281.76% |
| Change in Net Operating Assets | 190.67% | 53.64% | 48.01% | -61.96% | -58.85% |
| Cash from Operations | 210.80% | 3.93% | 16.89% | -62.09% | -64.36% |
| Capital Expenditure | -28.06% | -46.51% | 12.64% | 23.50% | 27.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 16.00% | -10.53% | -866.67% | 96.04% |
| Divestitures | -97.64% | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -227.31% | 195.02% | 220.40% | 233.33% | 115.95% |
| Total Debt Issued | -- | -- | -- | -92.16% | -100.00% |
| Total Debt Repaid | 55.22% | -174.94% | -145.41% | 63.21% | 59.64% |
| Issuance of Common Stock | 83.33% | 57.14% | -66.67% | -68.75% | -64.71% |
| Repurchase of Common Stock | -26.73% | -365.85% | -25.83% | 33.46% | 77.80% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 67.52% | -- | -- | -430.43% | -303.45% |
| Cash from Financing | 47.88% | -9,642.86% | -26.42% | -2.39% | -266.14% |
| Foreign Exchange rate Adjustments | -327.78% | -57.50% | -110.00% | 85.71% | 160.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 150.00% | -82.83% | 142.11% | -131.40% | -534.78% |